Use of intraperitoneal 5-fluorouracil and chlorhexidine for prevention of recurrence of perforated colorectal carcinoma in a rat model

Diseases of the Colon and Rectum

Volumn 40, Issue 9, 1997, Pages 1085-1088

  Stuntz, Michael ^a   Wilmoth, Gerald ^a   Ong, Jane ^a   Stabile, Bruce ^a   Stamos, Michael ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

5 Fluorouracil; Chlorhexidine; Intraperitoneal; Perforated colorectal cancer; Rat; Recurrence

Indexed keywords

CHLORHEXIDINE; FLUOROURACIL;

ABDOMINAL ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RECURRENCE; COLON PERFORATION; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; DISINFECTION; MALE; NONHUMAN; PERITONEUM LAVAGE; RAT; RECTUM PERFORATION;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIMETABOLITES, ANTINEOPLASTIC; CHLORHEXIDINE; COLORECTAL NEOPLASMS; FLUOROURACIL; INTRAOPERATIVE PERIOD; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; PERITONEAL LAVAGE; RATS; RATS, SPRAGUE-DAWLEY; RUPTURE, SPONTANEOUS;

EID: 0030810517     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02050934     Document Type: Article

References (15)

1. American Cancer Society. Cancer Facts and figures -1994. Atlanta: American Cancer Society, 1994.
2. Slanetz CA Jr. The effect of inadvetent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum 1984;27:792-7.
3. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990;33:610-4.
4. Markman M. Second-line chemotherapy for refractory cancer: intraperitoneal chemotherapy. Semin Surg Oncol 1994;10:299-304.
5. Nordlinger B, Panis Y, Puts JP, Herve JP, Delelo R, Ballet F. Experimental model of colon cancer: recurrences after surgery alone or associated with intraperitoneal 5-flourouracil chemotherapy. Dis Colon Rectum 1991;34:658-63.
6. Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Prospective, randomized trial of intravenous 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985;98:414-21.
7. Sugarbaker PH, Cunliffe WJ, Belliveau J, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83-97.
8. Sugarbaker PH. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Dis Colon Rectum 1994;37(Suppl): S115-22.
9. Takahashi T, Hagiwara A, Shimotsuma M, Sawai K, Yamaguchi T. Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with Mitomycin C bound to activated carbon particles. World J Surg 1995;19:565-9.
10. Leather AJ, Kocjan G, Savage F, et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994; 37:814-9.
11. Archer S, Gray B. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases. Surgery 1990;108:502-7.
12. Long RT, Edwards RH. Implantation metastasis as a cause of local recurrence of colorectal carcinoma. Am J Surg 1989;157:194-201.
13. Umpleby HC, Williamson RC. Anastomotic recurrence in large bowel cancer. Br J Surg 1987;74:873-8.
14. Umpleby HC, Williamson RC. The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl 1984;66:192-4.
15. Xu S, Qian L, Zhang Z. The prompt killing effect of chlorhexidine on human colorectal carcinoma cell lines in vitro. Postgrad Gen Surg 1991;3:109-12.